2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine and Supranuclear Palsy, Progressive

2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine has been researched along with Supranuclear Palsy, Progressive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angelini, G; Garibaldi, S; Marinelli, L; Menini, S; Norese, R; Odetti, P; Perry, G; Siedlak, S; Smith, MA; Tabaton, M; Traverso, N; Valentini, S; Zaccheo, D	1

Other Studies

1 other study(ies) available for 2-formyl-5-(hydroxymethyl)pyrrole-1-norleucine and Supranuclear Palsy, Progressive

Article	Year
Lipoperoxidation is selectively involved in progressive supranuclear palsy. Journal of neuropathology and experimental neurology, 2000, Volume: 59, Issue:5 Topics: Aged; Aldehydes; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipid Peroxides; Lysine; Mesencephalon; Middle Aged; Norleucine; Pyrroles; Reference Values; Supranuclear Palsy, Progressive; tau Proteins; Thiobarbituric Acid Reactive Substances	2000

Article

Year

Lipoperoxidation is selectively involved in progressive supranuclear palsy.

Journal of neuropathology and experimental neurology, 2000, Volume: 59, Issue:5

Topics: Aged; Aldehydes; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipid Peroxides; Lysine; Mesencephalon; Middle Aged; Norleucine; Pyrroles; Reference Values; Supranuclear Palsy, Progressive; tau Proteins; Thiobarbituric Acid Reactive Substances

2000